Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study
Cephalalgia · 2023-09 · 43 (9)
DOI: 10.1177/03331024231198792 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cephalalgia, online erschienen am 08.09.2023. Verfasst von Britt W H van der Arend und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: COVID-19, Migraine Disorders. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This longitudinal cohort study aimed to investigate changes in migraine-related outcomes following COVID-19 infection and vaccination.
Methods
We identified 547 clinically diagnosed migraine patients from the Leiden Headache Center who kept a headache E-diary during the COVID-19 pandemic (February 2020 to August 2022). We sent a questionnaire to register their COVID-19 infection and/or vaccination dates. After applying inclusion criteria, n = 59 participants could be included in the infection analysis and n = 147 could be included in the vaccination analysis. Primary outcome was the change in monthly migraine days (MMD) between 1 month prior and 1 month post COVID-19 infection or vaccination. Secondary outcome variables were change in monthly headache days (MHD) and monthly acute medication days (MAMD).
Results
Vaccination against COVID-19 was associated with an increase in MMD (1.06; 95% confidence interval [CI] = 0.57–1.55; p < 0.001), MHD (1.52; 95% CI = 0.91–2.14; p < 0.001) and MAMD (0.72; 95% CI = 0.33–1.12; p < 0.001) in the first month post-vaccination. COVID-19 infection solely increased the number of MAMD (1.11; 95% CI = 0.10–1.62; p < 0.027), but no statistically significant differences in MMD or MHD were observed.
Conclusions
Our findings imply that vaccination against COVID-19 is associated with an increase in migraine, indicating a possible role of inflammatory mediators in migraine pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Internal Medicine, Erasmus University, Rotterdam, The Netherlands.
- Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Britt W H van der Arend
Zitieren
APA
van der Arend, B. W. H., Bloemhof, M. M., van der Schoor, A. G., van Zwet, E. W., & Terwindt, G. M. (2023). Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study. Cephalalgia, 43(9). https://doi.org/10.1177/03331024231198792
Vancouver
van der Arend BWH, Bloemhof MM, van der Schoor AG, van Zwet EW, Terwindt GM. Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study. Cephalalgia. 2023;43(9). doi:10.1177/03331024231198792
BibTeX
@article{vanderArend2023,
author = {van der Arend, Britt W H and Bloemhof, Mirthe M and van der Schoor, Alle G and van Zwet, Erik W and Terwindt, Gisela M},
title = {Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study},
journal = {Cephalalgia},
year = {2023},
volume = {43},
number = {9},
doi = {10.1177/03331024231198792}
}
EUVIMED